Rexinoids as Therapeutics for Alzheimer's Disease: Role of APOE.
Sign Up to like & getrecommendations! Published in 2017 at "Current topics in medicinal chemistry"
DOI: 10.2174/1568026616666160617090227
Abstract: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by amyloid plaques, composed of amyloid-beta peptide (Aβ) and neurofibrillary tangles, composed of aberrantly phosphorylated tau. APOE4 is the greatest genetic risk factor for AD, increasing… read more here.
Keywords: rexinoids therapeutics; apoe; alzheimer disease; disease ... See more keywords
Therapeutics of Alzheimer’s Disease: Recent Developments
Sign Up to like & getrecommendations! Published in 2022 at "Antioxidants"
DOI: 10.3390/antiox11122402
Abstract: With increasing aging, dementia is a growing public health concern globally. Patients with dementia have multiple psychological and behavioral changes, including depression, anxiety, inappropriate behavior, paranoia, agitation, and hallucinations. The major types of dementia are… read more here.
Keywords: alzheimer disease; disease recent; recent developments; dementia ... See more keywords